InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
IFN-α/β Reporter HEK 293 Cells | Differential immunomodulatory activity of tumor cell death induced by cancer ... | 2016 | Cancer Immunol Immunother. | Klein J.C. et al. | DOI: 10.1007/s00262-016-1828-3 |
Poly(I:C) LMW | Cleaved/Associated TLR3 Represents the Primary Form of the Signaling Receptor. | 2013 | J Immunol. | Toscano F. et al. | DOI: 10.4049/jimmunol.1202173 |
ODN 2395 - TLR9 ligand | Lipid-derived nanoparticles for immunostimulatory RNA adjuvant delivery. | 2012 | PNAS | Nguyen D.N. et al. | DOI: 10.1073/pnas.1121423109 |
ODN 2006 (ODN 7909) | Chromatin remodelling and autocrine TNFα are required for optimal interleukin... | 2015 | Nat Commun. | Zimmermann M. et al. | DOI: 10.1038/ncomms7061 |
G418 (Geneticin) | Infection of lymphoblastoid cell lines by Kaposi's sarcoma-associated herpesv... | 2011 | J.Virol. | Myoung J. & Ganem D. | DOI: 10.1128/JVI.05136-11 |
c-di-AMP | STING-dependent type I IFN production inhibits cell-mediated immunity to List... | 2014 | PLoS Pathog. | Archer K.A. et al. | DOI: 10.1371/journal.ppat.1003861 |
Hygromycin B Gold | A platform for rapid prototyping of synthetic gene networks in mammalian cells. | 2014 | Nucleic Acids Res. | Duportet X. et al. | DOI: 10.1093/nar/gku1082 |
NF-κB and NLRP3 inflammasome inhibitor - BAY 11-7082 | Toll-like receptor 11-initiated innate immune response in male mouse germ cells. | 2014 | Biol Reprod. | Chen Q. et al. | DOI: 10.1095/biolreprod.113.114421 |
pFUSE-rIgG-Fc (rabbit) | Classifying patients for breast cancer by detection of autoantibodies against... | 2014 | Cancer Prev Res (Phila). | Evans R.L. et al. | DOI: 10.1158/1940-6207.CAPR-13-0416 |
pFUSE-rIgG-Fc (rabbit) | Identification of the Low Density Lipoprotein (LDL) Receptor-related Protein... | 2013 | J Biol Chem. | Fernandez-Castaneda A. et al. | DOI: 10.1074/jbc.M112.384693 |
Recombinant human IL-4 protein - Bioactive cytokine | Priming of qualitatively superior human effector CD8+ T cells using TLR8 liga... | 2016 | J Immunol. | Lissina A. et al. | DOI: 10.4049/jimmunol.1501140 |
pFUSE-CHIg-mG1 | Role of Conserved E2 Residue W420 in Receptor Binding and Hepatitis C Virus I... | 2016 | J Virol. | Cowton V.M. et al. | DOI: 10.1128/JVI.00685-16 |
5'ppp-dsRNA | Viperin interaction with mitochondrial antiviral signaling protein (MAVS) lim... | 2017 | PLoS One. | Hee J.S. & Cresswell P. | DOI: 10.1371/journal.pone.0172236 |
293/MD2-CD14 | TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphory... | 2011 | PLoS One | Sakaguchi M. et al. | DOI: 10.1371/journal.pone.0023132 |
ODN 1826 - TLR9 ligand | Constitutive CD40 Signaling Calibrates Differentiation Outcomes in Responding... | 2016 | J Immunol. | Basu S. et al. | DOI: 10.4049/jimmunol.1600077 |
TDB VacciGrade™ | Local TNFR1 Signaling Licenses Murine Neutrophils for Increased TLR-Dependent... | 2017 | J Immunol. | Deguine J. et al. | DOI: 10.4049/jimmunol.1601465 |
TLR4 agonist preparation - MPLA-SM | Adjuvant Activity of Naturally Occurring Monophosphoryl Lipopolysaccharide P... | 2013 | Infect Immun. | Chilton P.M. et al. | DOI: 10.1128/IAI.01150-12 |
OVA peptides | TLR-Mediated Innate Production of IFN-{gamma} by CD8+ T Cells Is Independent ... | 2016 | J Immunol. | Salerno F. et al. | DOI: 10.4049/jimmunol.1501997 |
Mouse TLR4 Reporter HEK293 Cells (NF-κB) | AIEC pathobiont instigates chronic colitis in susceptible hosts by altering m... | 2014 | Gut | Chassaing B. et al. | DOI: 10.1136/gutjnl-2013-304909 |
LPS-RS | Site-specific regulation of P2X7 receptor function in microglia gates morphin... | 2017 | J Neurosci. | Leduc-Pessah H. et al. | DOI: 10.1523/JNEUROSCI.0852-17.2017 |